Kennedy Capital Management, Inc. Concert Pharmaceuticals, Inc. Transaction History

Kennedy Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.86 - $13.07 $1.22 Million - $3.28 Million	-250,804 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.48 - $12.84 $73,270 - $99,240	-7,729 Reduced 2.99%	250,804 $3.17 Million
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $47,034 - $58,698	-5,425 Reduced 2.06%	258,533 $2.54 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $28,048 - $41,425	3,596 Added 1.38%	263,958 $2.63 Million
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $990,676 - $2.17 Million	165,665 Added 174.94%	260,362 $2.3 Million
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $9,592 - $15,489	-1,680 Reduced 1.74%	94,697 $874,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $16,046 - $33,703	-2,729 Reduced 2.75%	96,377 $567,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $935,560 - $1.3 Million	99,106 New	99,106 $1.19 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.